---
title: "ORGO.US (ORGO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ORGO.US/news.md"
symbol: "ORGO.US"
name: "ORGO.US"
parent: "https://longbridge.com/en/quote/ORGO.US.md"
datetime: "2026-03-07T14:51:32.947Z"
locales:
  - [en](https://longbridge.com/en/quote/ORGO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ORGO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ORGO.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ORGO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ORGO.US/news.md)


# ORGO.US (ORGO.US) — Related News

### [Organogenesis (NASDAQ:ORGO) Posts Earnings Results, Beats Expectations By $0.03 EPS](https://longbridge.com/en/news/277108896.md)
*2026-02-26T22:33:06.000Z*
> Organogenesis (NASDAQ:ORGO) reported quarterly earnings of $0.24 EPS, exceeding expectations of $0.21 by $0.03. The comp

### [](https://longbridge.com/en/news/277104934.md)
*2026-02-26T22:01:25.000Z*
> Organogenesis Holdings shares are trading lower after the company reported Q4 financial results and issued FY26 sales gu

### [Organogenesis Q4 net product revenue jumps 78% on wound care growth](https://longbridge.com/en/news/277103347.md)
*2026-02-26T21:52:19.000Z*
> Organogenesis reported a 78% year-over-year increase in Q4 net product revenue, driven by an 83% rise in Advanced Wound 

### [Earnings Breakdown: Heron Therapeutics Q4](https://longbridge.com/en/news/277045813.md)
*2026-02-26T13:02:13.000Z*
> Heron Therapeutics (NASDAQ:HRTX) reported its Q4 earnings on February 26, 2026, beating estimates by 33.33% with an EPS 

### [Organogenesis | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 225.61 M](https://longbridge.com/en/news/277097486.md)
*2026-02-26T21:17:41.000Z*
### [Organogenesis Holdings Inc. (Nasdaq: ORGO) reports record revenue for the fourth quarter and year ended Dec. 31, 2025.](https://longbridge.com/en/news/277098946.md)
*2026-02-26T21:09:16.000Z*
> Organogenesis Holdings Inc., based in Canton, announced its financial results for the fourth quarter and full year endin

### [Organogenesis Q4 Net Product Revenue USD 225.1 Million](https://longbridge.com/en/news/277094809.md)
*2026-02-26T21:05:52.000Z*
> Feb 26 (Reuters) - Organogenesis Q4 operating income USD 63.3 million. * Q4 net income USD 43.7 million * Q4 adjusted EB

### [A Preview Of Organogenesis Hldgs's Earnings](https://longbridge.com/en/news/276928550.md)
*2026-02-25T19:01:42.000Z*
> Organogenesis Hldgs (NASDAQ:ORGO) is set to release its quarterly earnings report on February 26, 2026, with analysts ex